MMP9 and breast cancer: Thus, integrating this knowledge into our model, miR-34a and miR-200c have common targets (i.e., HIF-1α) and individual targets (e.g., MMP9, VEGFR), which, together, may decrease BC cell invasion, migration and angiogenesis (Figure 6).